Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Vantictumab (DHJ82501)

Host species:Human
Isotype:IgG2-lambda
Applications:Research Grade Biosimilar
Expression system:Mammalian Cells
Overview

Catalog No.

DHJ82501

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG2-lambda

Clonality

Monoclonal

Target

FzE1, Frizzled-1, hFz1, Fz-1, FZD1

Concentration

1.63 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9UP38

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

OMP-18R5, CAS: 1345009-45-1

Clone ID

Vantictumab

Data Image
  • SDS-PAGE
    SDS PAGE for Vantictumab
  • SEC-HPLC
    The purity of this product is >95% as determined by SEC-HPLC.
References

Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review), PMID: 29786110

Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review), PMID: 29048660

Molecular genetics and targeted therapy of WNT-related human diseases (Review), PMID: 28731148

A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer, PMID: 31338636

Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer, PMID: 32803633

Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations, PMID: 30622113

WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death, PMID: 28691093

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling, PMID: 29151594

Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. [DHJ82501]

Datasheet

Document Download

Research Grade Vantictumab.pdf

 

$ 328
Product specifications
100 μg 328 1 mg 1314

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Vantictumab [DHJ82501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only